Filing Flows › Sensus Healthcare (SRTS) › Stock forecast & fair value
Sensus Healthcare (SRTS) stock forecast and price target
Sensus Healthcare (SRTS) trades at $2.86. 4 analysts' median price target is $5.75 (+101%), from $4.00 to $6.00.
Sensus Healthcare's latest quarter
Sensus Healthcare, Q2 2026: revenue $2.3M (-69% year over year), operating margin -138.9%, net loss $8.7M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SRTS stock?
The median of 4 analysts' 12-month targets is $5.75, +101% from $2.86; the range is $4.00 to $6.00. The average rating is none.
Does Sensus Healthcare usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is SRTS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.